🇺🇸 FDA
Patent

US 10426786

Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids

granted A61KA61K31/439A61K31/5513

Quick answer

US patent 10426786 (Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids) held by The Regents of the University of California expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/439, A61K31/5513, A61K31/5517, A61K31/57